General MedicationsINTRAVENOUSGeneric

IFOSFAMIDE/MESNA KIT

IFOSFAMIDE; MESNA

Standard Dose

1GM/20ML;1GM/10ML (50MG/ML;100MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview IFOSFAMIDE/MESNA KIT is listed in Drugs@FDA under application 075874 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INTRAVENOUS - 1GM/20ML;1GM/10ML (50MG/ML;100MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2015-05-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview IFOSFAMIDE/MESNA KIT is listed in Drugs@FDA under application 075874 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INTRAVENOUS - 1GM/20ML;1GM/10ML (50MG/ML;100MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2015-05-26 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.